Vasiliki E Kalodimou
Director
Research and Regenerative Medicine Department, IASO Hospital
Greece
Biography
Vasiliki E. Kalodimou MSc, Ph.D is the director of the Flow Cytometry-Research and Regenerative Medicine Department at IASO Hospital in Athens, Greece. She has studied and worked with progenitor cells from placenta, umbilical cord, and adipose tissue along with their applications in regenerative medicine and flow cytometry, with publications in the field, including research fellowships. She has published 2 books about flow cytometry, the Greek edition was published in 2010 and in 2013 the book was published from AABB Press USA. In 2015 she was published her 3rd book, a handbook to mesenchymal stem cells in regenerative medicine by Specg.co She is a Flow Cytometry/Stem Cell Specialist, Leader at AABB CT Subsection: CT Product Manufacturing and Testing-USA, Scientific Consultant in Regenerative Plastic Surgery Institute / Pure Aesthetics, Brazil, AABB Assessor-USA, editor in 12 scientific journals, editor-in-chief in 4 scientific journals, and her biography was included in Who Is Who in the world 2014, 2015 & 2016 edition.
Research Interest
Since 2006, Dr. Kalodimou has studied and working with stem cells from placenta, umbilical cord and adipose tissue, in every day practice and their applications in regenerative medicine and Flow Cytometry. Also is working in the area of human genetics & population genetics. In collaboration with the Hellenic Flow Cytometry Society, Kalodimou has developed quality control schemes for stem cell marker enumeration. The goal of this work is to find helpful new applications for flow cytometry, evaluate the risk factors for stem cell infusion, and improve the clarity and accessibility of measurements by flow cytometry. Her work quantifies and ranks all risks of flow cytometry enumeration to prevent and minimize the false-positive results from different cytometer uses. She is also working to establish combinations of monoclonal antibodies for mesenchymal and adipose tissue stem cell enumeration. In addition to collaboration with state universities and pharmaceutical companies on research projects, Kalodimou frequently publishes her findings. The Greek edition of the book was published in 2010 and has been well-received while in 2013 the English edition of the book was puplished by AABB Press USA. She is a member of two subsections of the AABB Cellular Therapies Section and also an AABB assessor.